JB Reed/Bloomberg via Getty Images

Dr. Christopher Cannon, lead researcher on the 18-month study of heart disease patients, told USA Today that if the testing goes as well as expected in a larger-scale trial, “it may turn back the clock on heart disease and push it off the top of the list as the leading killer.”

  • Share
  • Read Later